1. Project
  2. CL-IO
  3. Organisations

Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis

Full project page

Organisations map overview


Powered by Chris Decubber BV